Cargando…
Efficacy of Intrapleural or Intrapericardial Injection of Single Bevacizumab in the Treatment of Lung Cancer-Mediated Malignant Effusion
The usage of bevacizumab for malignant pleural effusion (MPE) or malignant pericardial effusion (MPCE) has attracted increasing interest from researchers, but the precise ways of bevacizumab administration remain unknown. Patients with histologically or cytologically confirmed non-small-cell lung ca...
Autores principales: | He, Dongyun, Guo, Zhihua, Xie, Zixian, Zhang, Yalei, Deng, Qiuhua, Yang, Haihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9640233/ https://www.ncbi.nlm.nih.gov/pubmed/36353447 http://dx.doi.org/10.1155/2022/6763625 |
Ejemplares similares
-
Evaluation of efficacy and safety for bevacizumab in treating malignant pleural effusions caused by lung cancer through intrapleural injection
por: Zongwen, Sun, et al.
Publicado: (2017) -
Intrapericardial bevacizumab safely and effectively treats malignant pericardial effusion in advanced cancer patients
por: Chen, Dawei, et al.
Publicado: (2016) -
Better efficacy of intrapleural infusion of bevacizumab with pemetrexed for malignant pleural effusion mediated from nonsquamous non-small cell lung cancer
por: Song, Xinyu, et al.
Publicado: (2018) -
Sustained response of malignant pericardial effusion to intrapericardial bevacizumab in an advanced lung cancer patient: a case report and literature review
por: Chen, Dawei, et al.
Publicado: (2015) -
Intrapleural Injection of Anti-PD1 Antibody: A Novel Management of Malignant Pleural Effusion
por: Li, Xinying, et al.
Publicado: (2021)